基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
The pharmacological interventions currently available to control type 2 diabetes mellitus(T2DM)show a wide interindividual variability in drug response,emphasizing the importance of a personalized,more effective medical treatment for each individual patient.In this context,a growing interest has emerged in recent years and has focused on pharmacogenetics,a discipline aimed at understanding the variability in patients’drug response,making it possible to predict which drug is best for each patient and at what doses.Recent pharmacological and clinical evidences indicate that genetic polymorphisms(or genetic variations)of certain genes can adversely affect drug response and therapeutic efficacy of oral hypoglycemic agents in patients with T2DM,through pharmacokinetic-and/or pharmacodynamic-based mechanisms that may reduce the therapeutic effects or increase toxicity.For example,genetic variants in genes encoding enzymes of the cytochrome P-450 superfamily,or proteins of the ATP-sensitive potassium channel on the beta-cell of the pancreas,are responsible for the interindividual variability of drug response to sulfonylureas in patients with T2DM.Instead,genetic variants in the genes that encode for the organic cation transporters of metformin have been related to changes in both pharmacodynamic and pharmacokinetic responses to metformin in metformin-treated patients.Thus,based on the individual’s genotype,the possibility,in these subjects,of a personalized therapy constitutes the main goal of pharmacogenetics,directly leading to the development of the right medicine for the right patient.Undoubtedly,this represents an integral part of the translational medicine network.
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Pharmacogenetics of type 2 diabetes mellitus:An example of success in clinical and translational medicine
来源期刊 世界转化医学杂志 学科 医学
关键词 Type 2 diabetes ANTI-DIABETIC drugs PERSONALIZED therapy Genetic VARIANTS GENOME-WIDE association study
年,卷(期) 2014,(3) 所属期刊栏目
研究方向 页码范围 141-149
页数 9页 分类号 R
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2014(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Type
2
diabetes
ANTI-DIABETIC
drugs
PERSONALIZED
therapy
Genetic
VARIANTS
GENOME-WIDE
association
study
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
世界转化医学杂志
其它
2220-6132
北京市朝阳区东四环中路62号楼远洋国际中
出版文献量(篇)
48
总下载数(次)
0
总被引数(次)
0
论文1v1指导